Large-scale analysis of disease pathways in the human interactome
  Discovering disease pathways, which can be defined as sets of proteins
associated with a given disease, is an important problem that has the potential
to provide clinically actionable insights for disease diagnosis, prognosis, and
treatment. Computational methods aid the discovery by relying on
protein-protein interaction (PPI) networks. They start with a few known
disease-associated proteins and aim to find the rest of the pathway by
exploring the PPI network around the known disease proteins. However, the
success of such methods has been limited, and failure cases have not been well
understood. Here we study the PPI network structure of 519 disease pathways. We
find that 90% of pathways do not correspond to single well-connected components
in the PPI network. Instead, proteins associated with a single disease tend to
form many separate connected components/regions in the network. We then
evaluate state-of-the-art disease pathway discovery methods and show that their
performance is especially poor on diseases with disconnected pathways. Thus, we
conclude that network connectivity structure alone may not be sufficient for
disease pathway discovery. However, we show that higher-order network
structures, such as small subgraphs of the pathway, provide a promising
direction for the development of new methods.
